A Pilot Assessment of Caregivers' and Patients' Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population.

Q2 Medicine

Journal of Pediatric Pharmacology and Therapeutics Pub Date : 2025-08-01 Epub Date: 2025-08-11 DOI:10.5863/JPPT-24-00071

Elizabeth B Ferengul, Lauren M Oliveri, Leslie Briars, Lewis L Hsu, Paige Reilly, Sara W Hovey

{"title":"A Pilot Assessment of Caregivers' and Patients' Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population.","authors":"Elizabeth B Ferengul, Lauren M Oliveri, Leslie Briars, Lewis L Hsu, Paige Reilly, Sara W Hovey","doi":"10.5863/JPPT-24-00071","DOIUrl":null,"url":null,"abstract":"Objective: The purpose of this survey was to evaluate knowledge and perception of naloxone among patients with sickle cell disease and their caregivers.Methods: A 13-question survey about naloxone and the subject's perception of naloxone was developed by the research team and reviewed by 5 advocates for pediatric patients with sickle cell disease. The survey was offered to patient-caregivers and patients ≥12 years old with sickle cell disease and a prescription for home opioid medication. The survey was conducted during a clinic visit or inpatient admission with a convenience sampling strategy.Results: A total of 23 surveys were completed (9 patients and 14 caregivers). Nine of 23 subjects (40%) said they had heard of naloxone. Three subjects had naloxone at home. Only 3 caregivers said having naloxone at home would change their opioid use behavior.Conclusion: There is a lack of awareness about naloxone in the pediatric sickle cell disease population. Those who were aware of naloxone did feel it was an important medication and appeared to have a positive view of it.","PeriodicalId":37484,"journal":{"name":"Journal of Pediatric Pharmacology and Therapeutics","volume":"30 4","pages":"498-503"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351457/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5863/JPPT-24-00071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The purpose of this survey was to evaluate knowledge and perception of naloxone among patients with sickle cell disease and their caregivers.

Methods: A 13-question survey about naloxone and the subject's perception of naloxone was developed by the research team and reviewed by 5 advocates for pediatric patients with sickle cell disease. The survey was offered to patient-caregivers and patients ≥12 years old with sickle cell disease and a prescription for home opioid medication. The survey was conducted during a clinic visit or inpatient admission with a convenience sampling strategy.

Results: A total of 23 surveys were completed (9 patients and 14 caregivers). Nine of 23 subjects (40%) said they had heard of naloxone. Three subjects had naloxone at home. Only 3 caregivers said having naloxone at home would change their opioid use behavior.

Conclusion: There is a lack of awareness about naloxone in the pediatric sickle cell disease population. Those who were aware of naloxone did feel it was an important medication and appeared to have a positive view of it.

查看原文本刊更多论文

儿童镰状细胞人群中护理人员和患者对纳洛酮共同处方认知的初步评估。

目的：本调查旨在评估镰状细胞病患者及其护理人员对纳洛酮的认识和认知。方法：由课题组制定一份关于纳洛酮及受试者对纳洛酮认知的13个问题的调查，并由5名儿科镰状细胞病患者的倡导者进行审查。该调查提供给患者护理人员和≥12岁的镰状细胞病患者，并处方家庭阿片类药物。该调查是在门诊就诊或住院期间进行的，采用方便的抽样策略。结果：共完成问卷调查23份（9名患者和14名护理人员）。23名受试者中有9名（40%）说他们听说过纳洛酮。3名受试者在家服用纳洛酮。只有3名护理人员表示，家中使用纳洛酮会改变他们的阿片类药物使用行为。结论：儿童镰状细胞病患者对纳洛酮的认识不足。那些知道纳洛酮的人确实觉得它是一种重要的药物，似乎对它有积极的看法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pediatric Pharmacology and Therapeutics Medicine-Pediatrics, Perinatology and Child Health

CiteScore

2.40

自引率

0.00%

发文量

期刊介绍： The Journal of Pediatric Pharmacology and Therapeutics is the official journal of the Pediatric Pharmacy Advocacy Group. JPPT is a peer-reviewed multi disciplinary journal that is devoted to promoting the safe and effective use of medications in infants and children. To this end, the journal publishes practical information for all practitioners who provide care to pediatric patients. Each issue includes review articles, original clinical investigations, case reports, editorials, and other information relevant to pediatric medication therapy. The Journal focuses all work on issues related to the practice of pediatric pharmacology and therapeutics. The scope of content includes pharmacotherapy, extemporaneous compounding, dosing, methods of medication administration, medication error prevention, and legislative issues. The Journal will contain original research, review articles, short subjects, case reports, clinical investigations, editorials, and news from such organizations as the Pediatric Pharmacy Advocacy Group, the FDA, the American Academy of Pediatrics, the American Society of Health-System Pharmacists, and so on.